-       Report 
- February 2025
-  137 Pages 
- Canada 
   From       €2280EUR$2,549USD£2,006GBP 
      €2682EUR$2,999USD£2,360GBP 
          -       Report 
- September 2023
-  80 Pages 
- Israel 
   From       €3131EUR$3,500USD£2,754GBP 
          -       Report 
- September 2022
-  169 Pages 
- North America 
   From       €3086EUR$3,450USD£2,714GBP 
          -       Report 
- September 2022
-  166 Pages 
   From       €3086EUR$3,450USD£2,714GBP 
          -       Report 
- September 2022
-  174 Pages 
- Middle East, Africa 
   From       €3086EUR$3,450USD£2,714GBP 
           -       Report 
- September 2022
-  187 Pages 
- Europe 
   From       €3086EUR$3,450USD£2,714GBP 
          -       Report 
- September 2022
-  185 Pages 
- Asia Pacific 
   From       €3086EUR$3,450USD£2,714GBP 
          -       Report 
- July 2023
-  49 Pages 
- Europe 
   From       €313EUR$350USD£275GBP 
          -       Report 
- December 2024
-  38 Pages 
- Indonesia 
   From       €313EUR$350USD£275GBP 
          -       Report 
- December 2024
-  46 Pages 
- India 
   From       €313EUR$350USD£275GBP 
          -       Report 
- December 2024
-  45 Pages 
- China 
   From       €313EUR$350USD£275GBP 
          -       Report 
- December 2024
-  38 Pages 
- Brazil 
   From       €313EUR$350USD£275GBP 
          -       Report 
- December 2024
-  38 Pages 
- United States 
   From       €313EUR$350USD£275GBP 
          -       Report 
- December 2024
-  37 Pages 
- Mexico 
   From       €313EUR$350USD£275GBP 
          -       Report 
- December 2024
-  36 Pages 
- Canada 
   From       €313EUR$350USD£275GBP 
          -       Report 
- December 2024
-  40 Pages 
- South Africa 
   From       €313EUR$350USD£275GBP 
          -       Report 
- December 2024
-  40 Pages 
-  Denmark, Norway, Sweden Denmark, Norway, Sweden  
   From       €313EUR$350USD£275GBP 
          -       Report 
- December 2024
-  40 Pages 
- North America 
   From       €313EUR$350USD£275GBP 
          -       Report 
- December 2024
-  47 Pages 
- Europe 
   From       €313EUR$350USD£275GBP 
          -       Report 
- December 2024
-  41 Pages 
- Asia Pacific 
   From       €313EUR$350USD£275GBP 
       
      Branded generics are generic drugs that are marketed under a brand name. They are typically manufactured by a generic drug company, but are sold under a brand name owned by a pharmaceutical company. Branded generics are typically sold at a higher price than generic drugs, but are still much cheaper than the original brand-name drug. They are often used to increase the market share of a generic drug company, as well as to increase the visibility of a generic drug in the marketplace.
Branded generics    are becoming increasingly popular in the pharmaceutical industry, as they offer a cost-effective alternative to brand-name drugs. They are also used to increase the market share of generic drug companies, as well as to increase the visibility of generic drugs in the marketplace.
Some companies in the branded generics market include Teva Pharmaceuticals, Mylan, Sandoz, and Dr. Reddy's Laboratories. Show Less   Read more